Banco De Sabadell, S.A Dr Reddys Laboratories LTD Transaction History

Banco De Sabadell, S.A

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$62.12 - $74.2 $725,872 - $867,027	-11,685 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$57.98 - $73.08 $223,049 - $281,138	-3,847 Reduced 24.77%	11,685 $715,000
Q4 2019 Feb 14, 2020	SELL	$36.66 - $41.78 $235,173 - $268,018	-6,415 Reduced 29.23%	15,532 $632,000
Q3 2018 Nov 16, 2018	BUY	$29.25 - $36.73 $149,175 - $187,322	5,100 Added 30.27%	21,947 $763,000
Q1 2018 May 16, 2018	BUY	$31.93 - $39.54 $537,924 - $666,130	16,847 New	16,847 $549,000

245

23.2M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.56B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

Stay updated on Banco De Sabadell, S.A with notifications on news.